Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-23
DOI
10.3389/fnins.2017.00658
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes
- (2017) Laura Scott et al. EXPERIMENTAL NEUROLOGY
- Meta-analysis: Association of Helicobacter pylori infection with Parkinson's diseases
- (2017) Xiaoli Shen et al. HELICOBACTER
- Disparate effects of training on brain activation in Parkinson disease
- (2017) Inbal Maidan et al. NEUROLOGY
- Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
- (2017) Fabrizio Stocchi et al. NEUROLOGY
- PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease
- (2017) Yasuo Miki et al. NEUROSCIENCE LETTERS
- Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?
- (2017) Sara Redenšek et al. Frontiers in Aging Neuroscience
- Earlier Intervention with Deep Brain Stimulation for Parkinson’s Disease
- (2017) Gerson Suarez-Cedeno et al. Parkinsons Disease
- Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson�s disease: a pilot, single-blind, randomized controlled trial
- (2016) Alessandro Picelli FUNCTIONAL NEUROLOGY
- Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission
- (2016) Sarah Beggiato et al. JOURNAL OF NEUROCHEMISTRY
- Familial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes
- (2016) Tereza Bartonikova et al. MEDICINE
- Mutation inADORA1identified as likely cause of early-onset parkinsonism and cognitive dysfunction
- (2016) Elham Jaberi et al. MOVEMENT DISORDERS
- Antidyskinetic effect of A2Aand 5HT1A/1Breceptor ligands in two animal models of Parkinson's disease
- (2016) Annalisa Pinna et al. MOVEMENT DISORDERS
- Neuroprotection by caffeine in the MPTP model of parkinson’s disease and its dependence on adenosine A 2A receptors
- (2016) K. Xu et al. NEUROSCIENCE
- Electroconvulsive therapy in Parkinson´s disease
- (2015) Humberto Calderón-Fajardo et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues
- (2015) Mietha M. Van der Walt et al. BIOORGANIC CHEMISTRY
- Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease
- (2015) Jacobus Petzer et al. CURRENT MEDICINAL CHEMISTRY
- Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs
- (2015) Anne Michel et al. PLoS One
- Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain
- (2015) N D Volkow et al. Translational Psychiatry
- Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease
- (2014) Sheng Deng et al. ACTA NEUROLOGICA BELGICA
- Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors
- (2014) Peter J. Clark et al. BEHAVIOURAL BRAIN RESEARCH
- Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats
- (2014) V. Fernandez-Duenas et al. Disease Models & Mechanisms
- l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies
- (2014) Annalisa Pinna et al. EXPERIMENTAL NEUROLOGY
- Quantitative evaluation of electroconvulsive therapy for Parkinson’s disease with refractory psychiatric symptoms
- (2014) Kenya Nishioka et al. JOURNAL OF NEURAL TRANSMISSION
- Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
- (2014) Robert A Hauser et al. LANCET NEUROLOGY
- Unprecedented Therapeutic Potential with a Combination of A2A/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease
- (2014) Anne Michel et al. PLoS One
- A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats
- (2013) N. Jones et al. BRAIN RESEARCH BULLETIN
- Istradefylline: First Global Approval
- (2013) Rosselle Dungo et al. DRUGS
- Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2Aantagonism
- (2013) Lyndsey E. Collins-Praino et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Exposure to pesticides or solvents and risk of Parkinson disease
- (2013) G. Pezzoli et al. NEUROLOGY
- l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus
- (2013) Jordi Bonaventura et al. NEUROPHARMACOLOGY
- Exercise attenuates levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned mice
- (2013) A.S. Aguiar et al. NEUROSCIENCE
- Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease
- (2013) Krystyna Gołembiowska et al. NEUROTOXICITY RESEARCH
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Meta-analysis of early nonmotor features and risk factors for Parkinson disease
- (2012) Alastair J. Noyce et al. ANNALS OF NEUROLOGY
- Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum
- (2012) Pierre Trifilieff et al. BIOTECHNIQUES
- A2A/D2 receptor heteromerization in a model of Parkinson's disease. Focus on striatal aminoacidergic signaling
- (2012) Luca Ferraro et al. BRAIN RESEARCH
- Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: Studies with a mouse model of parkinsonian tremor
- (2012) John D. Salamone et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease
- (2012) Patricia K. Sonsalla et al. EXPERIMENTAL NEUROLOGY
- A Novel Conjugated Agent between Dopamine and an A2A Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach
- (2012) Alessandro Dalpiaz et al. MOLECULAR PHARMACEUTICS
- Associations of welding and manganese exposure with Parkinson disease: Review and meta-analysis
- (2012) J. A. Mortimer et al. NEUROLOGY
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- Transcranial direct-current stimulation modulates synaptic mechanisms involved in associative learning in behaving rabbits
- (2012) J. Marquez-Ruiz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Is Pesticide Use Related to Parkinson Disease? Some Clues to Heterogeneity in Study Results
- (2011) Marianne van der Mark et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Future Treatments for Parkinson's Disease: Surfing the PD Pipeline
- (2011) Robert A. Hauser INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes
- (2011) David Crosiers et al. JOURNAL OF CHEMICAL NEUROANATOMY
- The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease
- (2011) A. Tozzi et al. JOURNAL OF NEUROSCIENCE
- Transcranial direct current stimulation for the treatment of focal hand dystonia
- (2011) David H. Benninger et al. MOVEMENT DISORDERS
- Enhanced neurodegeneration after a high dose of methamphetamine in adenosine A3 receptor null mutant mice
- (2011) H. Shen et al. NEUROSCIENCE
- Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists
- (2011) Marco Orru et al. PLoS One
- Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling
- (2011) Ahmed-Ramadan Sadek et al. Purinergic Signalling
- The role of parkin in familial and sporadic Parkinson's disease
- (2010) Ted M. Dawson et al. MOVEMENT DISORDERS
- Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice
- (2010) Daniel Marcellino et al. NEUROBIOLOGY OF DISEASE
- Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats
- (2009) Lu Song et al. BRAIN RESEARCH
- Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by Anti-Parkinsonian Drug Therapy In Vivo
- (2009) Tobias Gyárfás et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Blockade of adenosine A2A receptors downregulates DARPP-32 but increases ERK1/2 activity in striatum of dopamine deficient “weaver” mouse
- (2009) Konstantinos Botsakis et al. NEUROCHEMISTRY INTERNATIONAL
- Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance
- (2009) Roberto Maggio et al. PARKINSONISM & RELATED DISORDERS
- GIGYF2 mutations are not a frequent cause of familial Parkinson's disease
- (2009) Alessio Di Fonzo et al. PARKINSONISM & RELATED DISORDERS
- Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease
- (2008) Corinne Lautier et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Aging and Sedentarism Decrease Vascularization and VEGF Levels in the Rat Substantia Nigra. Implications for Parkinson's Disease
- (2008) Begoña Villar-Cheda et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- (2008) M. Stacy et al. NEUROLOGY
- Dopamine D2 and Adenosine A2A Receptors Regulate NMDA-Mediated Excitation in Accumbens Neurons Through A2A–D2 Receptor Heteromerization
- (2008) Karima Azdad et al. NEUROPSYCHOPHARMACOLOGY
- Decreased behavioral activation following caffeine, amphetamine and darkness in A3 adenosine receptor knock-out mice
- (2008) Olga Björklund et al. PHYSIOLOGY & BEHAVIOR
- Peripheral nucleotide hydrolysis in rats submitted to a model of electroconvulsive therapy
- (2008) João Vicente Busnello et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat
- (2008) John E. Kelsey et al. PSYCHOPHARMACOLOGY
- CSC, an adenosine A2A receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats
- (2007) Lissiana M.V. Aguiar et al. BRAIN RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started